Riker Lauren Bullaro's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Feb 3, 2026
- Accession no.
- 0001628280-26-005158
- Filed
- Feb 3, 2026
- Trade date
- Jan 30-Feb 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $83.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Riker Lauren BullaroCIK 0001545439 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Common Stock | FTax withholdingDisposed | −2,751 | $20.54 | −$56,505.54 | 56,313.24 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −4,000 | $20.81 | −$83,240 | 52,313.24 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.